Alterola Biotech, Inc. (ABTI)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2020 2019 2018 2017
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses 1.69 Million 6.47 Million 329.51 Thousand 258.45 Thousand 122.55 Thousand 49.13 Thousand
Selling, General and Administrative Expenses 1.65 Million 4.03 Million 329.51 Thousand 258.45 Thousand 122.55 Thousand 46.54 Thousand
Research and Development Expenses 46.42 Thousand 2.43 Million - - - -
Other Expenses 1.41 Million - 79 Thousand 257.93 Thousand 122.2 Thousand 2583.00
Cost and Expenses 1.69 Million 6.47 Million 329.51 Thousand 258.45 Thousand 122.55 Thousand 49.13 Thousand
Operating Income -1.89 Million -6.47 Million -329.51 Thousand -258.45 Thousand -122.55 Thousand -49.13 Thousand
Interest Expense - 1.00 - 249.00 10.51 Thousand 18.5 Thousand
Income Tax Expense -154.52 Thousand -1.00 -79 Thousand - - 18.5 Thousand
Earnings before Tax -1.69 Million -6.47 Million -250.51 Thousand -258.7 Thousand -133.06 Thousand -67.63 Thousand
Net Income -1.54 Million -6.47 Million -171.51 Thousand -258.7 Thousand -133.06 Thousand -86.13 Thousand
Earnings Per Share Basic -0.00 -0.01 -0.00 -0.00 -0.00 -0.00
Earnings Per Share Diluted -0.00 -0.01 -0.00 -0.00 -0.00 -0.00
Weighted Average Shares Outstanding 806.33 Million 769.96 Million 118.06 Million 116.56 Million 115.61 Million 114.98 Million
Weighted Average Shares Outstanding (Diluted) 806.33 Million 769.96 Million 118.06 Million 116.56 Million 115.61 Million 114.98 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -1.69 Million -6.47 Million -250.51 Thousand -258.45 Thousand -122.55 Thousand -46.54 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts